Premenstrual Dysphoric Disorder (PMDD) is being highlighted as a severe, debilitating condition that can lead to extreme psychological distress and suicidal ideation.
Medical researchers are investigating why the brain may be a primary treatment target, particularly for patients who do not respond to standard SSRIs or hormonal therapies.
The condition affects a significant portion of the population, with new studies focusing on the neurological pathways that trigger these intense premenstrual symptoms.